Announcements Trials
Browse Landscape

Status

Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 6Observational 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Sezary Syndrome 2Mycosis Fungoides 2

Interventions

Flow Cytometry 5Polymerase Chain Reaction 4Therapeutics 3Psychiatric Rehabilitation 3Immunoenzyme Techniques 3Blood Specimen Collection 3mogamulizumab 2Amplified Fragment Length Polymorphism Analysis 2Watchful Waiting 1Valganciclovir 1Urine Specimen Collection 1Standard of Care 1Photopheresis 1Peripheral Blood Stem Cell Transplantation 1Microarray Analysis 1Methoxsalen 1Influenza Vaccines 1Indium 1Immunosuppression Therapy 1Immunohistochemistry 1Hematologic Tests 1Gene Rearrangement 1Gene Expression Profiling 1Ganciclovir 1Foscarnet 1Fentanyl 1Drug Therapy 1Data Collection 1Dapsone 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Sezary Syndrome × mogamulizumab × Clear all
NCT07132567 2025-09-22

Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance

Kyowa Kirin Co., Ltd.

Recruiting
15 enrolled
Lymphoid

Mycosis Fungoides, Sezary Syndrome

NCT05455931 2024-09-04

PROSPER

Kyowa Kirin Co., Ltd.

Active not recruiting
73 enrolled
Lymphoid

Mycosis Fungoides, Sezary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡